Clinical Trials Logo

Gastrectomy clinical trials

View clinical trials related to Gastrectomy.

Filter by:

NCT ID: NCT06403540 Recruiting - Clinical trials for Colorectal Neoplasms

The Impact of Laparotomy and Analgesia Methods on Diaphragm

Start date: January 30, 2024
Phase:
Study type: Observational

Major abdominal surgeries are traditionally performed via laparotomy. Analgesia is routinely administered during the postoperative period. The goal is to investigate the effects of laparotomy and analgesia methods on diaphragm function.

NCT ID: NCT06354348 Completed - Sarcopenia Clinical Trials

Practical Ultrasonographic Detection of Sarcopenia in Patients With Long-term Gastrectomy

Start date: December 6, 2023
Phase: N/A
Study type: Interventional

The investigators aimed to evaluate long-term sarcopenia in patients with total and distal gastrectomy by measuring the anterior thigh muscle with USG, which is a more specific and easy method.

NCT ID: NCT06062225 Not yet recruiting - Clinical trials for Postoperative Complications

Protocol for Comparing the Efficacy of Three Reconstruction Methods of the Digestive Tract After Proximal Gastrectomy

Start date: October 2023
Phase: N/A
Study type: Interventional

The efficacy of three different reconstruction methods after proximal gastrectomy will be investigated in this study through a prospective, multicenter, randomized controlled trial.

NCT ID: NCT06058442 Recruiting - Gastrectomy Clinical Trials

The Pancreatic Enzymes After Gastrectomy Trial

Start date: January 24, 2024
Phase: Phase 3
Study type: Interventional

This trial evaluates the effects (e.g. on quality of life, weight) of NORTASE® compared to standard care of patients who have undergone gastrectomy.

NCT ID: NCT05495217 Active, not recruiting - Laparoscopy Clinical Trials

A Clinical Study for Comparison of the Effects Between Gasless Laparoscopy and Conventional Laparoscopy for Distal Gastric Cancer

Start date: December 1, 2021
Phase: N/A
Study type: Interventional

The aim of this trial is to confirm the non-inferiority of Gasless laparoscopy-assisted distal D2 radical gastrectomy to the conventional laparoscopy-assisted distal D2 radical gastrectomy for the treatment of advanced gastric cancer patients (T2-4a, N0-3, M0).

NCT ID: NCT05161572 Recruiting - Stomach Neoplasms Clinical Trials

Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer

NeoRacing
Start date: September 28, 2021
Phase: Phase 2
Study type: Interventional

NeoRacing is a randomized phase II trial carried out at Fudan University Shanghai Cancer Center (FUSCC) in China. The study can be divided into the screening stage, treatment stage and follow-up stage. The enrolled patients will receive perioperative SOX chemotherapy, PD-1 antibody (sintilimab) and radical surgery, with or without preoperative CRT. The patients were randomized by stratified permutated block randomization on a web-based system . The status of peritoneal cytological examination (CY0 vs. CY1) was the stratification factor. The study protocol was approved by the Ethics Committee of FUSCC. All patients provided written informed consent before recruitment. Monitoring will be carried out in this tri

NCT ID: NCT05071755 Not yet recruiting - Gastric Cancer Clinical Trials

Gastrectomy Outcomes in Elderly Patients

GOE
Start date: November 1, 2021
Phase:
Study type: Observational

In this study, the investigators aimed to identify independent prognostic factors for early postoperative complications and survival in elderly patients (aged ≥65 years) with gastric cancer.

NCT ID: NCT04798820 Recruiting - Gastric Cancer Clinical Trials

The Effect of Intensive Dietary Education on Nutritional Status After Gastrectomy(SING)

SING
Start date: March 9, 2021
Phase: N/A
Study type: Interventional

Radical gastrectomy has been known as the most effective treatment of curable gastric cancer.However, there is a high risk of malnutrition and weight loss after a gastrectomy which may be attributed to inadequate oral consumption, malabsorption and loss of the reservoir function of the stomach.Weight loss has been regarded as an independent risk factor for postoperative mortality and morbidity and It is also closely associated with a quality of life after surgery. No specific surgical technique has been proved to be effective in reducing postoperative weight loss and it seems like that dietary education and consultation is the best way to minimize weight loss in gastrectomy patients in clinical setting. In this regard, the investigators performed a retrospective pilot study to identify the effect of routinely performed (simplified) dietary education on nutritional status after gastrectomy, but it revealed that the effect of simplified dietary education on weight loss was not clear and the result implies that more intensive dietary education may be necessary after gastrectomy. The aim of this randomized controlled trial (RCT) is to elucidate the effect of intensive dietary education on nutritional status after gastrectomy in comparison with simplified dietary education.

NCT ID: NCT04607057 Recruiting - Gastric Cancer Clinical Trials

Supplemental Parenteral Nutrition During Postgastrectomy in Nutritionally at Risk Patient

SUPPORT
Start date: December 22, 2020
Phase: Phase 4
Study type: Interventional

- If a patient undergoes gastrectomy, which is a kind of major abdominal operation, he/she loses more than 5% of his/her body weight in 2 months after surgery. This point is one of the criteria of 'risk of malnutrition' according to Nutrition Risk Screening (NRS 2002) and the patient who corresponds to this criterion needs nutritional support. - According to Nutrition Risk Screening (NRS 2002), moderate malnutrition is defined as the state that the patient orally intakes 25~50% of recommended requirements; severe malnutrition is less than 25%. - Meanwhile, when oral nutrition support was provided to patients after gastric cancer surgery, the patients' average daily intake during the first three months was about a half of the recommended requirements. - Putting together the facts i) that the patient underwent major abdominal operation, ii) that the weight loss rate exceeded 5% for two months, iii) that the average daily intake of patients during the first three months was about half of the recommended amount, the patients are eligible to be classified as a group who require nutritional support according to NRS 2002. Therefore, it is intended to verify the efficacy and safety of supplemental parenteral nutrition by comparing Arm A, who are provided oral intake with supplemental parenteral nutrition, Arm B, who are provided oral intake only after curative gastric cancer surgery.

NCT ID: NCT04422236 Active, not recruiting - Obesity Clinical Trials

A Post-market, Observational Registry With the easyEndoTM Universal Linear Cutting Stapler in Laparoscopic Bariatric Surgery

STAP-Delta
Start date: September 28, 2020
Phase:
Study type: Observational [Patient Registry]

The purpose of this observational registry is to evaluate the safety and performance of the easyEndoTM Universal Linear Cutting Stapler and reloads from Ezisurg Medical when used to create anastomoses during laparoscopic bariatric surgery. The goal of the study will be achieved by assessing the device performance and by reporting of peri- and postoperative complications in a prospectively maintained database.